Monday, August 20, 2018
IBB 115.88 0.41 (0.35%)XBI 93.28 0.71 (0.76%)
Ticker Current Price Change Graph
IBB 115.88 0.41 (0.35%)
XBI 93.28 0.71 (0.76%)
Last updated: ago
Sign in to Endpoints
Menu Search
  • Special Reports
  • Deep Dives
  • ENDPOINTS 100
  • News
  • Protocols
  • Bioregnum
  • Endpoints Careers
  • About
  • Advertise
  • Privacy Policy
  • Reader center

Right on the heels of $150M raise, Ascentage files the latest in a rush of HKEX biotech IPOs — but is the market too jittery?

by Amber Tongenvelope — on August 20, 2018 10:39 AM EDT

Housing AstraZeneca’s old R&D efforts in antibiotics, Entasis files for $86M IPO

by Brittany Meilingenvelope — on August 20, 2018 09:55 AM EDT

As Shkreli attorney Greebel heads to his own prison cell, the bad boy of biotech is still skewering enemies in new blog

by John Carrollenvelope — on August 20, 2018 09:21 AM EDT
Updated: 09:31 AM

AbbVie, Sanofi-backed Principia offers an $86M IPO after burning through $148M for pipeline work

by John Carrollenvelope — on August 20, 2018 07:23 AM EDT

Harbour BioMed jumps into the crowded PD-1/L1 race, looking to take a Chinese asset global as checkpoint pipeline bulges

by Amber Tongenvelope — on August 20, 2018 07:20 AM EDT

PPD Biotech panel: Five leaders in the Boston hub evaluate the top trends — and where we’re all headed in the next 5 years

Sponsored Post

by John Carrollenvelope — on August 20, 2018 07:00 AM EDT

Roche picks up a speedy nod in China as regulators follow through on plans for a fast 48 new drug OKs

by John Carrollenvelope — on August 20, 2018 06:09 AM EDT

Outspoken researcher Peter Bach urges CMS to consider ways of bringing down CAR-T prices — and offers a few suggestions

by Brittany Meilingenvelope — on August 17, 2018 10:31 AM EDT

John Kaiser finds next CEO role at Duke spinout Evecxia; Immunocore vet Namir Hassan moves to I/O biotech Zelluna

by Amber Tongenvelope — on August 17, 2018 09:45 AM EDT

Just a few days after a stumble, FDA OKs 12-week dose for Eylea as Regeneron braces for Novartis attack

by John Carrollenvelope — on August 17, 2018 07:58 AM EDT
Updated: 08:02 AM

  • 1
  • 2
  • 3
  • 359

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
  • Endpoints Careers
  • About Endpoints
  • Privacy Policy
  • Advertise/Media Kit

copyright 2018 Endpoints Company

Yes, I'd like to subscribe No, thanks
I'm already a subscriber
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
Sure No
← Go back

Sign in to Endpoints News

I forgot my password Request a magic link
← Go back

Request a magic link

Enter your email below to get a Magic link which lets you sign in quickly without using a password.
Please note the Magic link is one-time use only and valid for only 24 hours.
← Go back

Set a new password

We will send you a link, with which you will be able to set a new password.
Please note this link is one-time use only and valid for only 24 hours.